Vildagliptin Sustained-release Tablets(Taizhou Overseas Pharma)
维格列汀缓释片（越洋医药）
Report date: 2025/08/20 15:56:21
Base Information
Drug NameVildagliptin Sustained-release Tablets(Taizhou Overseas Pharma)
Drug Alias Name +[7]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesTaizhou Overseas Pharmaceuticals Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesTaizhou Overseas Pharmaceuticals Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A